急性肝衰竭:重新定义综合征
J G O'Grady1, S W Schalm, R Williams
1Institute of Liver Studies, King's College School of Medicine and Dentistry, London, UK.
Lancet (London, England)
|July 31, 1993
概括
急性肝衰竭 (ALF) 的新术语区分了超急性,急性和亚急性形式,基于黄到脑病变的时间. 这种分类提高了对临床特征,预后的理解,并有助于标准化临床试验,以更好地管理患者.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 临床医学 临床医学
- 医学术语 医学术语 医学术语
背景情况:
- 目前的急性肝衰竭 (ALF) 定义不能充分捕捉临床表现和患者结局的变化.
- 在ALF患者的临床特征和预后中存在显著差异.
研究的目的:
- 提出一种新的,精细的术语来分类急性肝衰竭综合征.
- 改善在ALF分类中准确反映临床特征和预后.
- 帮助管理ALF患者和标准化临床试验.
主要方法:
- 在伦敦国王学院医院 (1972-1985) 治疗ALF的大型患者队列的分析.
- 根据黄发作和脑病变发展之间的间隔进行分类.
主要成果:
- 过敏肝衰竭:黄发作后7天内发生脑病变;尽管有脑,但在医疗治疗下生存率高.
- 急性肝衰竭:黄后8-28天的脑病变;大脑发的高发病率,如果没有移植,预后更差.
- 亚急性肝衰竭:黄后5-12周发生脑病变;脑发病率低,预后不佳.
结论:
- 拟议的术语 (超急性,急性,亚急性肝衰竭) 更好地定义了ALF内的不同的临床综合征.
- 这种分类有助于患者管理,并为治疗试验提供了标准化的框架.
- 准确的分类对于理解急性肝衰竭的预后和指导治疗决策至关重要.
相关概念视频
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
